A new medical device based on a proprietary mixture of natural ingredients for the relief of gastroesophageal reflux symptoms.
Marketing Tools for Gastroesophageal Line
Download the brochureProduct background
Gastroesophageal reflux disease (GERD) is a condition in which the stomach contents leak backwards from the stomach into the esophagus (the tube from the mouth to the stomach). This can irritate the esophagus and cause heartburn and other symptoms. Nowadays, GERD is a common condition and its prevalence varies in different parts of the world. Several population-based studies have reported its prevalence is more frequent in Western than in Eastern countries. GERD is treated via a stepwise approach that is based on lifestyle modifications and control of gastric secretion by means of medical or surgical treatment. RefluGTM is a medical device that acts locally without systemic absorption via a multiple mechanism of action. It is specially formulated to relieve symptoms of GERD fast.
Key ingredients
Standardized complex of Galactomannan fiber, calcium carbonate, sodium carbonate, Malva sylvestris, hyaluronic acid.
Target
Symptoms associated with esophageal reflux (moderate uncomplicated GERD), reflux esophagitis, acid regurgitation, gastric acidity, heartburn and occasional digestive issues.
Benefits and features
- Proprietary mixture of natural ingredients.
- Approved indications for the management
of gastroesophageal reflux symptoms (MD class IIa). - 3-in-one product: anti-reflux, gastric mucosa barrier, antacid.
- With a clinically proven natural Galactomannnan fiber.
- Forms a raft barrier within minutes.
- Alginates and aluminum-free.
- Low in sodium.
- Pleasant natural mild flavor.
- Easy-to-use single dose liquid stick pack.
Scientific evidences and proprietary studies
Evaluation of raft-forming capacity of a medical device in liquid stick packs (data on file). Anti-heartburn effects of a fenugreek fiber product. (DiSilvestro et al 2010). Efficacy and tolerability of a novel galactomannan-based formulation for symptomatic treatment of gastroesophageal reflux disease: a randomized, double-blind, placebo-controlled study (Abenavoli et al 2021).
*Registered as “Antireflusso (NB 0476)”.
RELATED PRODUCTS
Marketing Tools for Gastroesophageal Line
Download the brochure| Product name | RefluGTM |
| Status | Medical Device class IIa |
| Key ingredients | Standardized complex of Galactomannan fiber, calcium carbonate, sodium carbonate, Malva sylvestris, hyaluronic acid. |
| Target and indication | Symptoms associated with esophageal reflux (moderate uncomplicated GERD), reflux esophagitis, acid regurgitation, gastric acidity, heartburn and occasional digestive issues. |
| Claims EFSA | n. a. |
| Scientific evidences and study | Evaluation of raft-forming capacity of a medical device in liquid stick packs (data on file). Anti-heartburn effects of a fenugreek fiber product. (DiSilvestro et al 2010). Efficacy and tolerability of a novel galactomannan-based formulation for symptomatic treatment of gastroesophageal reflux disease: a randomized, double-blind, placebo-controlled study (Abenavoli et al 2021). |
| Pharmaceutical form | Liquid stick pack (10 ml). 20 sticks package. |